Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
A Gene That Keeps Stem Cells From Losing Their Way
Article
April 30, 2026
A Gene That Keeps Stem Cells From Losing Their Way
Scientists find a gene essential for keeping intestinal stem cells stable, offering insight into how tissues repair themselves.
News Release Research (Publication) Yamanaka Lab Stem Cells/iPSCsAI Discovery Reveals DNA Isn’t Locked Away in Cells After All
Article
April 29, 2026
AI Discovery Reveals DNA Isn’t Locked Away in Cells After All
A new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Aging AIA Universal Toolkit for Editing Bacterial DNA
Article
April 23, 2026
A Universal Toolkit for Editing Bacterial DNA
Scientists at Gladstone expanded their retron-based genome editing technology beyond E. coli, showing it works in 15 diverse bacterial species.
News Release Research (Publication) Data Science and Biotechnology Shipman Lab CRISPR/Gene Editing